In pharmaphorum, reporter Nicole Raleigh spotlights Gothenburg’s rise as one of Europe’s most dynamic life sciences hubs, describing how the region now accounts for more than a third of Sweden’s total business R&D expenditure. Her piece highlights the country’s broader momentum — from major acquisitions and government sustainability investments to cutting‑edge academic research and biotech breakthroughs — illustrating how Sweden’s collaborative model between industry, academia and the public sector continues to fuel innovation.

Raleigh’s visit to GoCo Health Innovation City showcases this ecosystem in action, including Thermo Fisher Scientific’s newly opened bioanalytical laboratory and its partnership with AstraZeneca’s BioVentureHub. Leaders from both organisations outline how co‑location, shared capabilities and Sweden’s deep talent pool create ideal conditions for next‑generation drug development, digital health integration and cross‑sector innovation. The article frames Gothenburg as a uniquely fertile environment where global companies, start‑ups and researchers converge — and where Sweden’s culture of openness and resource‑sharing is driving life sciences growth well beyond its size.

Read the full article here.